SEC Form 4 · accession 0000911916-16-000687
CoLucid Pharmaceuticals, Inc. · CLCD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Linda C. Hogan
Officer — Head, Bus. Dev. and Strategy
Period of report
Nov 1, 2016
Accepted (ET)
Nov 1, 2016 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348649
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 1, 2016 | M | 719 | $6.75 | A | 719 | D | |
| Common StockF1 | Nov 1, 2016 | S | 719 | $30.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $6.75 | Nov 1, 2016 | M | 719 | D | — | Mar 4, 2026 | Common Stock | 719 | 28,031 | D |
Explanation of responses
- F1Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Ms. Hogan on March 24, 2016.
- F2Options vest in a series of 48 successive equal monthly installments with the first monthly installment vesting on the grant date and the future installments vesting on the first day of each calendar month.